The efficacy and tolerability of pomalidomide in relapsed/refractory myeloma patients in a "real-world" study: the Royal Marsden Hospital experience
Tools
Sriskandarajah, P., Pawlyn, C., Mohammed, K., Dearden, C. E., Davies, F. E., Morgan, G. J., Boyd, K. D., Kaiser, M. F.
(2017)
The efficacy and tolerability of pomalidomide in relapsed/refractory myeloma patients in a "real-world" study: the Royal Marsden Hospital experience.
LEUKEMIA & LYMPHOMA, 58 (2).
pp. 494-497.
ISSN 1042-8194
Full text not available from this repository.
Item Type: | Letter |
---|---|
Authors (ICR Faculty only): | Morgan, Gareth and Davies, Faith |
All Authors: | Sriskandarajah, P., Pawlyn, C., Mohammed, K., Dearden, C. E., Davies, F. E., Morgan, G. J., Boyd, K. D., Kaiser, M. F. |
Additional Information: | ISI Document Delivery No.: ED1JH Times Cited: 0 Cited Reference Count: 14 Sriskandarajah, Priya Pawlyn, Charlotte Mohammed, Kabir Dearden, Claire E. Davies, Faith E. Morgan, Gareth J. Boyd, Kevin D. Kaiser, Martin F. 0 TAYLOR & FRANCIS LTD ABINGDON LEUKEMIA LYMPHOMA |
Uncontrolled Keywords: | REFRACTORY MULTIPLE-MYELOMA LOW-DOSE DEXAMETHASONE SURVIVAL BORTEZOMIB TRIAL IMIDS |
Research teams: | ICR divisions > Clinical Studies > Molecular Haematology (including Cytogenetics Group and Cell Markers) ICR divisions > Molecular Pathology > Molecular Haematology (including Cytogenetics Group and Cell Markers) Closed research groups > Myeloma Targeted Treatment |
Depositing User: | Barry Jenkins |
Date Deposited: | 05 Jan 2017 12:05 |
Last Modified: | 05 Jan 2017 12:05 |
URI: | http://publications.icr.ac.uk/id/eprint/15535 |
Actions (login required)
![]() |
View Item |